Funding is key to any company’s growth. At the beginning of October, Marc Beer through Renovia secured more than $42 million worth of investment. In the medical world, developers must resonate with the company’s ideas and vision before investing. Marc Beer was able to win the hearts of investors through his futurist approach to pharmaceutical and biotechnology business. More importantly, the company received the funding due to its work in making a difference in women health. It is a reality that women health as a niche in pharmaceutical and biotechnology is partially neglected.
The funding will enable Renovia to expand their systems and eventually their vision. According to the CEO, Marc Beer, the funding will also give Renovia the ability to improve efficiency in their systems and make the entity more digitalized. Digitalization will have a great impact on making pelvic treatments easier to administer. The investors were also satisfied with the Renovia approach to medicine and treatment. The relevant authorities (for example Food and Drug Administration) have satisfied all the Renovia products. Learn more: https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer
Two years ago, together with Ramon Iglesias, Marc started one of the most innovative companies in the medical field. He is a passionate investor and Renovia is, without a doubt the future of specialized women healthcare. Specifically, on pelvic floor disorders, Marc Beer is optimistic that this entity will continue to make a difference to thousands of women in need of personalized treatment. Marc is also keen on the research aspect of Renovia in proving up to date treatments. The business structure of Renovia is unique and well thought according to pharmaceutical and biotechnology pundits.
For close to three decades, Marc Beer has exceptionally great in the management of pharmaceutical and biotechnology companies. These industries require high levels of discipline and organizational skills. He has not only exhibited these skills but he has also been a role model to thousands of young leaders in pharmaceutical and biotechnology companies. As part of his professional growth and developed, Marc has been fortunate to work in different companies under different capacities. In all these capacities, he has given the entities a new path of profitability and sustainability. As part of the growth also, Marc Beer has been keen on expanding the companies’ capacities to accommodate more employees.
What is the future of Renovia? With the funding the company has received this year, the future of this company can only be bright. Currently, Renovia is one of the few companies in this medical niche to have a fully functional treatment with digital support. Digitalization, according to medical pundits is the future of medicine. In addition, Marc Beer has been able to constitute a very experienced management team to steer the company to the next dispensation and more importantly help the company achieve its goals.